L

Lineage Cell Therapeutics Inc
TASE:LCTX

Watchlist Manager
Lineage Cell Therapeutics Inc
TASE:LCTX
Watchlist
Price: 357.6 ILS -0.11%
Market Cap: 179.9m ILS

Relative Value

The Relative Value of one LCTX stock under the Base Case scenario is 1 011.56 ILS. Compared to the current market price of 357.6 ILS, Lineage Cell Therapeutics Inc is Undervalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LCTX Relative Value
Base Case
1 011.56 ILS
Undervaluation 65%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
73
Median 3Y
5.4
Median 5Y
6.1
Industry
7.5
Forward
6.5
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
23.6
Forward
-2.6
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-2
Industry
20.2
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-1.1
Industry
22.9
vs History
68
vs Industry
74
Median 3Y
0.8
Median 5Y
0.9
Industry
2.8
vs History
55
vs Industry
29
Median 3Y
0.6
Median 5Y
1.1
Industry
7.7
Forward
0.7
vs History
57
vs Industry
26
Median 3Y
0.7
Median 5Y
1.2
Industry
9.6
vs History
vs Industry
18
Median 3Y
-0.3
Median 5Y
-0.4
Industry
4.9
Forward
-0.2
vs History
vs Industry
16
Median 3Y
-0.3
Median 5Y
-0.4
Industry
4.9
Forward
-0.2
vs History
vs Industry
21
Median 3Y
-0.3
Median 5Y
-0.5
Industry
5.4
vs History
vs Industry
17
Median 3Y
-0.2
Median 5Y
-0.5
Industry
4
vs History
58
vs Industry
45
Median 3Y
0.1
Median 5Y
0.2
Industry
5.1

Multiples Across Competitors

LCTX Competitors Multiples
Lineage Cell Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lineage Cell Therapeutics Inc
TASE:LCTX
179.9m ILS 5.6 -3.3 -0.3 -0.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 182 884.2 -162 466.2 -197 285.8 -195 034.5
US
Abbvie Inc
NYSE:ABBV
329.2B USD 5.7 79.2 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
157.3B USD 4.6 26.5 14.3 23.5
US
Gilead Sciences Inc
NASDAQ:GILD
135.8B USD 4.7 22.8 9.9 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.3B USD 10.7 -120.6 25.7 26.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 060.9 -525.9 -572.7 -557.4
AU
CSL Ltd
ASX:CSL
119.8B AUD 5.1 28.4 17.5 21.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.3B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.5B USD 17.3 -150.3 -673.5 -337.5
P/E Multiple
Earnings Growth PEG
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average P/E: 34
Negative Multiple: -3.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 466.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.8
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -120.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.4
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -150.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average EV/EBITDA: 15.7
Negative Multiple: -0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 285.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.5
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -673.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average EV/EBIT: 20.3
Negative Multiple: -0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 034.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.5
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.4 N/A N/A
AU
CSL Ltd
ASX:CSL
21.9
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -337.5 N/A N/A